Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Second-generation non-nucleosidic reverse transcriptase inhibitor HBY097 and HIV-1 viral load.

Lancet (London, England) - 24 May 1997

Rübsamen-Waigmann H, Huguenel E, Paessens A, Kleim J P, Wainberg M A, Shah A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acquired Immunodeficiency Syndrome
Share to Anti-HIV Agents
Share to Double-Blind Method
Share to Drug Combinations

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Placebos

Share to Quinoxalines

Share to Reverse Transcriptase Inhibitors

Share to Viremia

Source

Identifiers

PMID: 9167463
DOI: 10.1016/S0140-6736(97)24021-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Second-generation non-nucleosidic reverse transcriptase inhibitor HBY097 and HIV-1 viral load.PMID 9167463Read ↗

Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)Semantic proximity Read ↗

New nucleoside reverse transcriptase inhibitors for the treatment of HIV infectionsSemantic proximity Read ↗

New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infectionsSemantic proximity Read ↗

Los Angeles, New York, Stanford University: HBY 097, new drug may weaken HIV.Semantic proximity Read ↗

Improved HIV-1 RNA quantitation by COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test, v2.0 using a novel dual-target approachSemantic proximity Read ↗

Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudineSemantic proximity Read ↗

Review of viral load and combination therapy data from 35th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy.Semantic proximity Read ↗

Increased viral quasispecies evolution in HBeAg seroconverter patients treated with oral nucleoside therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.